The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2023

Filed:

Jan. 10, 2017
Applicant:

Technische Universiteit Eindhoven, Eindhoven, NL;

Inventors:

Keita Ito, Helmond, NL;

Stefan Antonius Henricus de Vries, Veldhoven, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/36 (2006.01); A61K 9/00 (2006.01); A61K 35/12 (2015.01); A61K 35/30 (2015.01);
U.S. Cl.
CPC ...
A61L 27/3608 (2013.01); A61K 9/0085 (2013.01); A61K 35/12 (2013.01); A61K 35/30 (2013.01); A61L 27/3604 (2013.01); A61L 27/365 (2013.01); A61L 27/3658 (2013.01); A61L 27/3683 (2013.01); A61L 27/3691 (2013.01); A61L 2430/38 (2013.01);
Abstract

A solubilized notochordal cell matrix powder dissolved in a carrier solvent or formed as a gel is provided. The notochordal cell matrix powder originates from lyophilized and treated porcine nucleus pulposus tissue containing notochordal cells. The powder contains less than 20% of porcine nucleid acids, and the powder contains a substantially unchanged amount of porcine protein content compared to the originating porcine nucleus pulposus tissue. The solubilized notochordal cell matrix powder is capable of stimulating native or stem cells to proliferate and produce a significant increase inglycosaminoglycansand type-II collagen matrix. Embodiments of the invention can be used for the disc regenerative treatment of discogenic back and neck pain in an orthopaedic and/or pharmaceutical setting/approach.


Find Patent Forward Citations

Loading…